Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
PeerJ Comput Sci ; 10: e1953, 2024.
Article in English | MEDLINE | ID: mdl-38660169

ABSTRACT

Melanoma is the most aggressive and prevalent form of skin cancer globally, with a higher incidence in men and individuals with fair skin. Early detection of melanoma is essential for the successful treatment and prevention of metastasis. In this context, deep learning methods, distinguished by their ability to perform automated and detailed analysis, extracting melanoma-specific features, have emerged. These approaches excel in performing large-scale analysis, optimizing time, and providing accurate diagnoses, contributing to timely treatments compared to conventional diagnostic methods. The present study offers a methodology to assess the effectiveness of an AlexNet-based convolutional neural network (CNN) in identifying early-stage melanomas. The model is trained on a balanced dataset of 10,605 dermoscopic images, and on modified datasets where hair, a potential obstructive factor, was detected and removed allowing for an assessment of how hair removal affects the model's overall performance. To perform hair removal, we propose a morphological algorithm combined with different filtering techniques for comparison: Fourier, Wavelet, average blur, and low-pass filters. The model is evaluated through 10-fold cross-validation and the metrics of accuracy, recall, precision, and the F1 score. The results demonstrate that the proposed model performs the best for the dataset where we implemented both a Wavelet filter and hair removal algorithm. It has an accuracy of 91.30%, a recall of 87%, a precision of 95.19%, and an F1 score of 90.91%.

2.
F1000Res ; 12: 14, 2023.
Article in English | MEDLINE | ID: mdl-38826575

ABSTRACT

Background: Glaucoma and diabetic retinopathy (DR) are the leading causes of irreversible retinal damage leading to blindness. Early detection of these diseases through regular screening is especially important to prevent progression. Retinal fundus imaging serves as the principal method for diagnosing glaucoma and DR. Consequently, automated detection of eye diseases represents a significant application of retinal image analysis. Compared with classical diagnostic techniques, image classification by convolutional neural networks (CNN) exhibits potential for effective eye disease detection. Methods: This paper proposes the use of MATLAB - retrained AlexNet CNN for computerized eye diseases identification, particularly glaucoma and diabetic retinopathy, by employing retinal fundus images. The acquisition of the database was carried out through free access databases and access upon request. A transfer learning technique was employed to retrain the AlexNet CNN for non-disease (Non_D), glaucoma (Sus_G) and diabetic retinopathy (Sus_R) classification. Moreover, model benchmarking was conducted using ResNet50 and GoogLeNet architectures. A Grad-CAM analysis is also incorporated for each eye condition examined. Results: Metrics for validation accuracy, false positives, false negatives, precision, and recall were reported. Validation accuracies for the NetTransfer (I-V) and netAlexNet ranged from 89.7% to 94.3%, demonstrating varied effectiveness in identifying Non_D, Sus_G, and Sus_R categories, with netAlexNet achieving a 93.2% accuracy in the benchmarking of models against netResNet50 at 93.8% and netGoogLeNet at 90.4%. Conclusions: This study demonstrates the efficacy of using a MATLAB-retrained AlexNet CNN for detecting glaucoma and diabetic retinopathy. It emphasizes the need for automated early detection tools, proposing CNNs as accessible solutions without replacing existing technologies.


Subject(s)
Diabetic Retinopathy , Glaucoma , Neural Networks, Computer , Humans , Diabetic Retinopathy/diagnostic imaging , Diabetic Retinopathy/diagnosis , Glaucoma/diagnosis , Glaucoma/diagnostic imaging , Artificial Intelligence
SELECTION OF CITATIONS
SEARCH DETAIL